Gadolinium-complexed Aβ-binding contrast agents for MRI diagnosis of Alzheimer's Disease

This publication has 21 references indexed in Scilit:

• Ushering in the study and treatment of preclinical Alzheimer disease
  Nature Reviews Neurology, 2013
• Florbetapir F-18: A Histopathologically Validated Beta-Amyloid Positron Emission Tomography Imaging Agent
  Seminars in Nuclear Medicine, 2011
• Facile synthesis of 1-(acetic acid)-4,7,10-tris(tert-butoxycarbonylmethyl)-1,4,7,10-tetraazacyclododecane: a reactive precursor chelating agent
  Tetrahedron Letters, 2009
• Designing Peptide Inhibitors for Oligomerization and Toxicity of Alzheimer's β-Amyloid Peptide
  Biochemistry, 2008
• Applications of a Blood-Brain Barrier Technology Platform to Predict CNS Penetration of Various Chemotherapeutic Agents. 2. Cationic Peptide Vectors for Brain Delivery
  Chemotherapy, 2007
• Predicting Solvent and Aggregation Effects of Peptides Using Group Contribution Calculations
  Biotechnology Progress, 2006
• In VivoMagnetic Resonance Microimaging of Individual Amyloid Plaques in Alzheimer's Transgenic Mice
  Journal of Neuroscience, 2005
• Synthesis of glycosyl derivatives as dopamine prodrugs: interaction with glucose carrier GLUT-1Electronic supplementary information (ESI) available: experimental details for the preparation of all derivatives and biological assays. See http://www.rsc.org/suppdata/ob/b2/b212066f/
  Organic & Biomolecular Chemistry, 2003
• Oligomerization and Toxicity of β-Amyloid-42 Implicated in Alzheimer's Disease
  Biochemical and Biophysical Research Communications, 2000
• Detection of neuritic plaques in Alzheimer’s disease by magnetic resonance microscopy
  Proceedings of the National Academy of Sciences, 1999